Exicure XCUR Stock
11 USD
{{ price }}
1.851850%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
71.65M USD
LOW - HIGH [24H]
11
-
11.59 USD
VOLUME [24H]
6.93K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-4.75 USD
Exicure Price Chart
Exicure XCUR Financial and Trading Overview
| Exicure stock price | 11 USD |
| Previous Close | 1.08 USD |
| Open | 1.1 USD |
| Bid | 0 USD x 1800 |
| Ask | 0 USD x 800 |
| Day's Range | 1.06 - 1.17 USD |
| 52 Week Range | 0.63 - 4.95 USD |
| Volume | 38.17K USD |
| Avg. Volume | 23.84K USD |
| Market Cap | 9.62M USD |
| Beta (5Y Monthly) | 0.973943 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.75 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
XCUR Valuation Measures
| Enterprise Value | 8.35M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.4935066 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.33378643 |
| Price/Book (mrq) | 0.3826955 |
| Enterprise Value/Revenue | 0.29 |
| Enterprise Value/EBITDA | -12.501 |
Trading Information
Exicure Stock Price History
| Beta (5Y Monthly) | 0.973943 |
| 52-Week Change | -68.31% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.95 USD |
| 52 Week Low | 0.63 USD |
| 50-Day Moving Average | 1 USD |
| 200-Day Moving Average | 1.23 USD |
XCUR Share Statistics
| Avg. Volume (3 month) | 23.84K USD |
| Avg. Daily Volume (10-Days) | 33.25K USD |
| Shares Outstanding | 8.37M |
| Float | 3.97M |
| Short Ratio | 6.74 |
| % Held by Insiders | 56.96% |
| % Held by Institutions | 12.46% |
| Shares Short | 127.11K |
| Short % of Float | 1.75% |
| Short % of Shares Outstanding | 1.52% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -8.95% |
| Operating Margin (ttm) | -6.35% |
| Gross Margin | 31.42% |
| EBITDA Margin | -2.31% |
Management Effectiveness
| Return on Assets (ttm) | -2.59% |
| Return on Equity (ttm) | -19.74% |
Income Statement
| Revenue (ttm) | 28.83M USD |
| Revenue Per Share (ttm) | 6.24 USD |
| Quarterly Revenue Growth (yoy) | 927.99% |
| Gross Profit (ttm) | 9.06M USD |
| EBITDA | -668000 USD |
| Net Income Avi to Common (ttm) | -2582000 USD |
| Diluted EPS (ttm) | -0.58 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.58M USD |
| Total Cash Per Share (mrq) | 1.03 USD |
| Total Debt (mrq) | 7.31M USD |
| Total Debt/Equity (mrq) | 48.96 USD |
| Current Ratio (mrq) | 6.132 |
| Book Value Per Share (mrq) | 3.005 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -35658000 USD |
| Levered Free Cash Flow (ttm) | -20408250 USD |
Profile of Exicure
| Country | United States |
| State | IL |
| City | Chicago |
| Address | 2430 North Halsted Street |
| ZIP | 60614 |
| Phone | 847 673 1700 |
| Website | https://www.exicuretx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 13 |
Exicure, Inc., an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
Q&A For Exicure Stock
What is a current XCUR stock price?
Exicure XCUR stock price today per share is 11 USD.
How to purchase Exicure stock?
You can buy XCUR shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Exicure?
The stock symbol or ticker of Exicure is XCUR.
Which industry does the Exicure company belong to?
The Exicure industry is Biotechnology.
How many shares does Exicure have in circulation?
The max supply of Exicure shares is 6.51M.
What is Exicure Price to Earnings Ratio (PE Ratio)?
Exicure PE Ratio is now.
What was Exicure earnings per share over the trailing 12 months (TTM)?
Exicure EPS is -4.75 USD over the trailing 12 months.
Which sector does the Exicure company belong to?
The Exicure sector is Healthcare.
Exicure XCUR included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17366.13 USD — |
-0.1
|
9.56B USD — | 17128.71 USD — | 17467.35 USD — | — - | 9.56B USD — |
| NASDAQ Capital Market Composite RCMP | 102.11 USD — |
-0.04
|
— — | 100.72 USD — | 103.65 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 931.02 USD — |
+0.81
|
— — | 921.75 USD — | 934.48 USD — | — - | — — |
- {{ link.label }} {{link}}